---
title: "Aperto® DCB: A breakthrough in prolonging dialysis access survival"
date: "2023-11-18T00:12:04.000Z"
publishedDate: "18 novembre 2023"
summary: "This advertorial is sponsored by Cardionovum. Cardionovum’s CE-marked Aperto drug-coated balloon (DCB) is, according to expert opinion and a growing evidence base, spearheading a revolution in the realm of vascular access maintenance for dialysis patients."
importance: ""
sourceUrl: "https://vascularnews.com/aperto-dcb-a-breakthrough-in-prolonging-dialysis-access-survival/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2023-11-18-apertor-dcb-a-breakthrough-in-prolonging-dialysis-access-survival"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/05/Matteo-Tozzi-2.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/aperto-dcb-a-breakthrough-in-prolonging-dialysis-access-survival/"
---

![Aperto® DCB: A breakthrough in prolonging dialysis access survival](https://vascularnews.com/wp-content/uploads/sites/7/2023/05/Matteo-Tozzi-2.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/aperto-dcb-a-breakthrough-in-prolonging-dialysis-access-survival/*

## L’essentiel

This advertorial is sponsored by Cardionovum. Cardionovum’s CE-marked Aperto drug-coated balloon (DCB) is, according to expert opinion and a growing evidence base, spearheading a revolution in the realm of vascular access maintenance for dialysis patients.

## Lien source

https://vascularnews.com/aperto-dcb-a-breakthrough-in-prolonging-dialysis-access-survival/
